Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GAPDHP17 (glyceraldehyde-3-phosphate dehydrogenase pseudogene 17) is a member of the GAPDH pseudogene family. It is a processed pseudogene (arising by retrotransposition) of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene, a well-known housekeeping enzyme with key roles in glycolysis. As with most processed pseudogenes, GAPDHP17 is considered non-functional at the protein level due to disabling sequence changes, and does not encode a functional enzyme. There is no evidence that GAPDHP17 is transcribed or has a regulatory RNA function. Its main significance lies in its utility as a genomic marker and its inclusion in analyses of pseudogene evolution or gene family structure. Pseudogenes in general are sometimes found to be transcribed, and rare cases report regulatory roles (such as acting as competitive endogenous RNAs or microRNA sponges), but no such functions have been documented for GAPDHP17. The parent gene, GAPDH, is a crucial metabolic enzyme and sometimes studied as a target or biomarker, but GAPDHP17 itself does not share these roles. In summary, GAPDHP17 is a processed pseudogene of GAPDH with no evidence of protein-coding function, biological significance, or therapeutic targeting potential.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 17 (GAPDHP17).